Affiliation and Location
University of Milan
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
Contacts and References
Head of Laboratory: Prof. Yvan Torrente
Neurologist, Full Professor of Neurology
yvan.torrente@unimi.it
The Laboratory of Innovative Therapies in Neuromuscular Diseases, directed by Prof. Yvan Torrente, operates within the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico. The Laboratory is dedicated to both basic and clinically applied scientific research, with a focus on neurodegenerative and neuromuscular pathologies.
Its activities aim to develop advanced therapies for musculoskeletal system disorders, such as muscular dystrophies, through a multidisciplinary and innovative approach.
The Laboratory is committed to studying the pathophysiology of neuromuscular diseases and investigating new therapeutic strategies based on:
Cell Therapy: Investigating the potential of stem cells for tissue repair and regeneration.
Gene Therapy: Developing methods to correct or compensate for genetic defects underlying muscle diseases.
Nanotechnology: Applying nanoscale materials and devices to treat neurodegenerative pathologies and improve drug delivery.
In particular, the research focuses on:
Immune System & Microbiota: Exploring the role of immune responses and gut flora composition in the progression of muscular dystrophies.
Advanced Modeling: Utilizing cutting-edge techniques to better understand disease mechanisms and test new therapeutic compounds.
Innovation is at the heart of the Laboratory’s activities, which utilizes an integrated approach combining basic research, clinical trials, and the development of new therapies to improve patients’ quality of life.
One of the primary research areas concerns the application of nanotechnologies in the treatment of neurodegenerative diseases. The use of ferromagnetic nanotubes enhances the biodistribution of exosomes and their in vivo targeting, making the treatment of muscular dystrophies more effective. Furthermore, the use of gold nanoparticles has shown promising results in reducing oxidative stress and improving mitochondrial function, with potential implications for treating conditions such as Friedreich’s ataxia.
Parallelly, the Laboratory explores the role of the microbiota in neuromuscular and neurodegenerative diseases. Research has highlighted a connection between alterations in the gut microbiota, inflammation, and muscle degeneration. In this context, strategies are being developed to modulate the microbiota through prebiotics, probiotics, and innovative therapies such as fecal microbiota transplantation, with the goal of improving muscle function and reducing inflammation.
The Laboratory is constantly committed to updating its research and collaborates with national and international institutions to develop increasingly effective therapeutic solutions. Thanks to an innovative and multidisciplinary approach, it continues to contribute significantly to the advancement of scientific knowledge and the improvement of therapies for neuromuscular and neurodegenerative diseases.
Prof. Yvan Torrente